| Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping EW Warner, K Van der Eecken, AJ Murtha, EM Kwan, C Herberts, J Sipola, ... Nature Cancer, 1-17, 2024 | 5 | 2024 |
| The microfluidic capture of single breast cancer cells for multi-drug resistance assays K Parekh, H Sharifi, A Khamenehfar, TV Beischlag, RTM Payer, PCH Li Methods in Enzymology 628, 113-127, 2019 | 3 | 2019 |
| Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer NM Fonseca, C Maurice-Dror, C Herberts, W Tu, W Fan, AJ Murtha, ... Nature Communications 15 (1), 1828, 2024 | 2 | 2024 |
| Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells K Parekh, HS Noghabi, JA Lopez, PCH Li Cancer Drug Resistance 3 (3), 613, 2020 | 2 | 2020 |
| Using Hepatic Gene Expression Assays in English Sole (Parophrys vetulus) to Investigate the Effects of Metro Vancouver Wastewater Effluents K Parekh, VL Marlatt Toxics 11 (8), 657, 2023 | 1 | 2023 |
| Impact of androgen deprivation therapy (ADT) on circulating tumor DNA (ctDNA) detection in de novo metastatic castration-sensitive prostate cancer (mCSPC). EM Kwan, AJ Murtha, W Tu, C Vasquez Rios, CQ Bernales, SK Arviola, ... Journal of Clinical Oncology 42 (4_suppl), 204-204, 2024 | | 2024 |
| Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer. A Munzur, J Sipola, C Seo, EM Kwan, K Parekh, CQ Bernales, ... Journal of Clinical Oncology 42 (4_suppl), 214-214, 2024 | | 2024 |
